Two cases with generalised bullous cutaneous reactions after COVID‐19 mRNA vaccine Moderna (Spikevax®) and Pfizer–BioNTech (Comirnaty®)
Rinnooy Kan, Charlotte E., Röckmann, Heike, Dijk, Marijke R., Ramsaransing, Tanuja, Reubsaet, Lieke L., Peters, Elke E. M., Vos, Lydia E.
Published in JEADV clinical practice (01.03.2024)
Published in JEADV clinical practice (01.03.2024)
Get full text
Journal Article